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Summary The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC) was established to
investigate the role of possible aetiological factors in childhood cancer, with particular emphasis on
environmental exposures to the foetus and family history of certain diseases including cancer. Incident cases
occurring in three Health Service regions (the West Midlands, Yorkshire and North Western) were matched
for age and sex with two sets of control children. A total of 555 cases and 1110 controls were entered into the
study. The parents of each index child were interviewed with respect to events during the relevant pregnancy,
occupation, smoking habits, and past medical history of themselves, the child's siblings and other relatives.
Ninety-three per cent of case parents approached agreed to be interviewed, and 90% of controls were
ranked first or second on the control selection lists. After the interview information was verified by reference
to antenatal and other medical records. Obstetric and general practitioner records were abstracted for -90%
of cases and controls. Information derived from the interview and that from medical records was coded
separately. The data collected by each region have been pooled and case-control comparisons of potential
aetiological factors will be carried out, using matched triplet analyses.
Cancer is second only to accidents as a cause ofdeath
in children aged between 1 and 14 years in England
and Wales where in 1980, 565 children between
these ages died of cancer (OPCS, 1982). The
incidence of childhood cancer in Great Britain is 10
per 100,000 per annum, representing about 1,300
cases per annum (Draper et al., 1982). Malignant
disease of the lympho-reticular system (including
leukaemias) accounts for more than 1/3 of the
cases; central nervous system (mostly brain)
tumours account for almost 1/4; the remainder
being mainly embryonal tumours. Carcinomas
which comprise the majority of cancers in adults
are extremely rare in children (Draper et al., 1982;
Birch, 1983). Although certain environmental and
genetic factors have been implicated in the
aetiology of childhood cancer, in the majority of
patients no obvious cause is apparent. Many
reports of associations with malformations or
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exposure to carcinogens, for example, have been
anecdotal and previous case-control studies can be
criticised on many grounds including lack of
numbers and biases in the selection of cases and
controls. It is clear that any study of the aetiology
of childhood cancer should attempt multi-variate
analyses of the many possible associations with
environmental and genetic factors. The Inter-
Regional Epidemiological Study of Childhood
Cancer (IRESCC) was established with this in
mind.
The main objectives of this study are: (i) to
compare each case with two matched control
children with respect to pre- and post-natal
exposure to environmental factors of putative aetio-
logical relevance; (ii) to compare the incidence of
various conditions, especially cancer, in the families
of cases with that in control families and with the
population in general. Detailed enquiries and
investigations have been made to establish extended
pedigrees of interesting families.
In this paper we describe the methodology
adopted for the study and consider the degree of
success of the project with respect to data
collection. The comparability of the data collected
for cases and controls among the three participating
regions is considered. The purpose of the paper is
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not only to discuss methodology but, in addition,
to provide detailed background information about
the study for future publications on case-control
analyses of aetiological factors.
Methods
Data collection - Ascertainment ofcases
The following were considered eligible for the study:
Children with malignant disease who were below 15 years
of age and resident in Yorkshire, West Midlands and
North Western Regional Health Authorities areas at the
time of their diagnoses, and who were diagnosed between
January 1980 and December 1982 (West Midlands); June
1980 and January 1983 (Yorkshire); and June 1980 and
December 1982 (North Western).
In addition, children fulfilling the above criteria but
with the following benign or borderline conditions were
also to be included: all intracranial tumours; histiocytosis
X; ganglioneuroma; benign teratomas; neurofibromatosis;
aggressive fibromatosis; aneurysmal bone cysts; all
endocrine tumours.
Children who were not living with their natural mother
for any reason were excluded. The research associates
regularly visited the wards of their respective regional
paediatric oncology centres and had close liaison with
clinical staff. Thus the parents of new patients in these
centres were approached soon after their child had been
diagnosed. Children treated outside the oncology centres
were identified through the West Midlands Regional
Cancer Registry, the Manchester Children's Tumour
Registry and the Yorkshire Regional Cancer Registry.
Ascertainment was therefore virtually complete (Leck et
al., 1976; Waterhouse, 1982). Parents of these children
were then approached via their consultants or general
practitioners as appropriate. In order to limit the case
load to numbers which could be managed by the available
staff, random selection procedures were adopted for
certain more common diagnoses in the West Midlands
and North West. (All sarcomas, Wilms' tumours, germ
cell tumours, lymphomas, hepatoblastomas and epithelial
tumours were included; one-third of all other cases were
eliminated).
Paediatric histopathologists and haematologists in each
of the regions are members of a national paediatric
oncology group, permitting confident classification of the
children's tumours. Moreover, the majority of the children
were entered into clinical trials, for many of which the
diagnoses were also confirmed by review panels of
paediatric pathologists. Inter-regional standardisation of
diagnoses was thus achieved for the majority of cases. In
Manchester all cases were reviewed by the Manchester
Children's Tumour Registry Pathologists Panel.
Selection ofcontrols
After the case child's parents had agreed to take part in
the study two controls were selected for each case. The
controls were matched for sex and age according to the
following rules:
(a) for case children aged below two years the control
child may be up to 3 months older but no younger;
(b) for case children aged between 2 and 10 years the
control child may be up to 6 months older but no
younger;
(c) for case children aged between 11 and 14 years the
control child may be up to 6 months older or younger.
The first set, designated GP controls, was chosen using a
random selection procedure from the lists of the general
practitioners (GP) or group practices with whom the cases
were registered, and the only exclusions were children who
had suffered neoplastic disease. The second set was chosen
from among children in hospital for reasons other than
neoplastic disease and who did not have any of the
following: (a) a genetic or other constitutional disease or
malformation known to be associated with increased risk
of cancer, e.g. Down's syndrome, hemihypertrophy,
Beckwith-Wiedemann syndrome, aniridia, von Hippel-
Lindau syndrome; (b) any other major malformation or
chronic disease, e.g., major skeletal anomalies, neural tube
defects, chromosomal disorders, Still's disease, epilepsy,
diabetes or major blood disorders.
Children with minor malformations, e.g. squint, and
less serious chronic conditions, e.g. hay fever, were
considered eligible providing that the condition was not
the reason for the child's admission to hospital. Controls
were selected mainly from among acute surgical and
accident cases. These children are designated 'hospital
controls'.
In each region arrangements were made with
appropriate local hospitals for selection of controls from
lists of paediatric admissions and approach to potential
control parents. The selection of hospital controls was
carried out by the research associate.
Detailed instructions on GP control selection were sent
to respective GPs who were given the option of selecting
suitable controls themselves or allowing a member of the
IRESCC staff to make the selection. The standard
procedure recommended by the Royal College of General
Practitioners was used. Where a GP made the selection
himself those selected were checked for eligibility by
IRESCC staff. Lists of all eligible hospital and GP
controls for each case were compiled and their names
arranged in a random order. After checking with the
consultant or GP of the first child on the respective list
that there was no objection, the parents were approached.
The parents of second and subsequent children on the
control lists were approached only if the parents of the
first child were not willling to take part in the study. Each
child selected as a control was equally well matched with
the case.
Approach to parents
Wherever possible parents of cases and hospital controls
were personally approached by the research associate. The
study was explained to them, including the type of
questions which would be asked at the interview, and
written information about the study and the interview was
also handed to them. Having gained their co-operation,
an appointment for the interview was made. The great
majority of case parents, but fewer hospital control
parents, were contacted in this way. GP control parents
and the parents of cases and hospital controls where a
personal approach was not possible were contacted byIRESCC STUDY DESIGN 917
letter, and similar written information concerning the
study and the types of question which would be asked at
interview were enclosed, together with a reply card. If no
reply was received after two to three weeks, the parents
were contacted again, by telephone if possible, and if the
parents did not agree to interview at this stage then those
cases were excluded from the study or alternative controls
were sought as applicable. When a case child had died,
the research associate was advised by the child's
consultant or GP about a suitable time to approach the
parents. Bereaved parents were approached only once,
generally by letter, and if their agreement to participate in
the study was not then secured the case was excluded.
Interviews
Interviews were usually carried out in the parents' homes
but occasionally took place in hospital. The interviews
were conducted according to a standard technique which
had been agreed and piloted before the main study began.
Group discussions with the research associates concerning
interpretation and administration of the interview pro-
forma were held at the outset of the study. Practice
interviews with parents of ineligible cases were carried out
and subsequently discussed. The research associates thus
became familiar with the pro-forma and the agreed
interview technique, before embarking on interviews with
eligible case parents. The interview forms included
questions on the index child's antenatal and previous
medical history, congenital malformations, immunizations
and exposures to X-rays, drugs and other potential
carcinogens. Check-lists of illnesses, malformations and
drugs were used in conjunction with the questionnaire to
prompt more accurate recall of information. Details were
also taken of the parents' past medical histories,
occupations, exposures to potential carcinogens and
mother's obstetric history. History of neoplasms, genetic
disease and other chronic disorders was obtained for
siblings and their offspring, grandparents, aunts, uncles
and first cousins.
Verification ofinformation obtained at interview
After the interview the mother's obstetric notes were
obtained and details of the index pregnancy were
abstracted onto a standard form. Information on the
outcome of the mother's other pregnancies and any
gynaecological problems was also recorded. The GP's
records were abstracted for details of the health of the
mother and child, particularly the health of the mother
during the index pregnancy.
If the index child had been admitted to hospital for any
serious condition the hospital notes were obtained and
details were similarly abstracted. Many illnesses in
siblings, parents and other relatives of the index child
reported at interview were confirmed by reference to
hospital or other medical records and standard abstract
forms were completed. Priority was given to the
verification of the following diagnoses in the index
children and their relatives: neoplastic disease, congenital
malformations, any known genetic disease and certain
major chronic conditions, e.g. diabetes and rheumatoid
arthritis. Hospital notes were used as the main source for
verification, but if these were not available other sources
such as cancer registrations and death certificates were
used. Thus for each case entered into the study a
completed set of data comprises interview pro-formas for
the case and two matched controls, and abstract forms
completed from medical records with respect to the
mothers' obstetric histories and medical histories of the
index children and their relatives. A completed data set is
hereafter referred to as a 'triplet'.
Preparation ofdatafor analysis
ICD-0 and ICD 9 (WHO 1976, 1978) were used to code
neoplastic and other diseases respectively. Code lists were
devised for the remaining data such that the information
could be coded in detail. Each region coded approxi-
mately one-third of the interview form and the respective
medical abstract form derived from all three regions. Thus
the same portion of the data provided from each of the
three separate centres was coded by one centre.
Information from the interview form was combined with
but coded separately from information on the medical
abstract form. Identifying data relating to the index child
was coded in a purely numerical form to preserve total
confidentiality. The data were subsequently pooled for
analysis.
Results
During the study period there were 761 incident
cases of childhood neoplasia in the three regions.
One hundred and forty six of these were excluded
mainly as a result of the procedures in operation in
the West Midlands and the North West to limit the
case load. Therefore, 615 cases were considered
eligible for interview and 555 interviews were
successfully obtained - 210 in the West Midlands,
182 in the North West and 163 in Yorkshire. Of
the 615 eligible cases 19 sets of parents were not
approached because either their GP or their
consultant thought that they would find it too
distressing to take part in the study. Of the 596 sets
of parents approached 41 did not wish to take part
in the study, i.e. 93% of case parents approached
agreed to be interviewed. Refusal rate among case
parents was similar in the three regions.
The distribution of diagnoses among interviewed,
non-interviewed and excluded cases is shown in
Table I. Forty-four per cent of interviewed cases
had leukaemias and other reticuloendothelial
neoplasms. Fifteen per cent and 13% had central
nervous system and connective tissue tumours
respectively. Wilms' tumours and neuroblastomas
each comprised -6% and just over 7% had germ
cell and trophoblastic tumours. Other rare tumours
represented in the study included retinoblastoma,
hepatoblastoma and various carcinomas.
Interviews with parents of GP and hospital
controls fulfilling the defined matching criteria were
carried out for each of the cases. Over 72% of GP
controls were ranked first and 20% second on the918 J.M. BIRCH et al.
Table I Distribution by diagnosis of interviewed and non-interviewed cases among all
eligible cases
Number NOT interviewed
Interviewed Parent GP/consultant
cases refusal refusal Exclusion
Diagnosis n (%) n n n
Leukaemia 171 (30.8) 12 4 45
Lymphoma and other
reticulo-endothelial
neoplasms 74 (13.3) 1 2 7
Central nervous system 81 (14.6) 14 5 57
Soft tissue sarcoma 42 (7.6) 1 0 3
Bone tumours 30 (5.4) 1 2 9
Wilms' and other complex
renal tumours 35 (6.3) 1 0 1
Neuroblastoma 35 (6.3) 2 1 11
Retinoblastoma 6 (1.1) 1 0 2
Hepatoblastoma 6 (1.1) 1 0 0
Germ cell and
trophoblastic tumours 41 (7.4) 2 2 3
Malignant epithelial tumours 20 (3.6) 3 0 2
Other malignant tumours 3 (0.5) 0 0 1
Other benign tumours 11 (2.0) 2 3 5
Total 555 (100.0) 41 19 146
lists of eligible controls. Among the hospital
controls 64% were ranked first and 22% second on
their respective lists. There was little variation
between regions with respect to rank order of
controls interviewed, except that a higher
proportion of hospital controls from Yorkshire
were ranked third or higher, i.e. 28% Yorkshire
compared with 11% Birmingham and 6%
Manchester.
Mothers of cases and controls were considered to
be the main source of information, but we aimed to
have both mother and father present at the inter-
view whenever possible. This was achieved for
- 59% of cases and 50% of each set of controls.
The majority of the remaining interviews were
carried out with the mother alone, but occasionally
another relative, usually the maternal grandmother,
was also present at the interview (Table II). Inter-
Table II Present at interview
Mother
Mother and and other
father Mother only relative
n (%) n (%) n (%)
Case 326 (58.7) 203 (36.6) 26 (4.7)
GP control 278 (50.1) 260 (46.8) 17 (3.1)
Hospital
control 276 (49.7) 266 (47.9) 13 (2.3)
views were carried out at a place convenient to the
parents, and for controls 98% were carried out in
homes, but 39% of case interviews were carried out
in the hospital. This was often necessary because
parents, especially mothers, would be spending
most of their time at the hospital with their sick
child.
Mean interview length was 53min in Yorkshire
(55min for cases, 51 min for GP controls and
53min for hospital controls); 96min in the West
Midlands (114min for cases, 83min for GP
controls and 90min for hospital controls); and
69min in Manchester (74min for cases and 66min
for both GP and hospital controls). The relatively
longer interview times in the West Midlands can be
partly explained due to extended pedigree infor-
mation being gathered in this region. It was
thought that variations in interview length may also
be related to ethnic group and this was examined
(Table III). There were 110 families in the study
population who were specified as belonging to an
ethnic group other than 'White European'. Inter-
view lengths did not markedly differ between ethnic
groups and no relation was found between inter-
view length and level of education of the parents.
Obstetric records were routinely sought and
abstracted after each interview and Table IV shows
the success of this exercise. On average 88% of sets
of obstetric notes were abstracted and the degree of
success was remarkably similar between regions andIRESCC STUDY DESIGN 919
Table III Interview length (min)
<40 40-59 60-79 80+ NR Total
n (0) n (%) n (%) n (%) n (%) t1 (%)
White European 148 (9.6) 564 (36.6) 248 (16.1) 513 (33.2) 69 (4.5) 1542 (92.6)
Indian/Pakistani 6 (7.4) 24 (29.6) 14 (17.3) 31 (38.3) 6 (7.4) 81 (4.9)
West Indian 4 (15.4) 7 (26.9) 2 (7.7) 11 (42.3) 2 (7.7) 26 (1.6)
Other and
unspecified 1 (6.3) 7 (43.7) 3 (18.7) 5 (31.3) 0 16 (0.9)
Total 159 602 267 560 77 1665 (100)
NR=not recorded.
Table IV Availability of obstetric records to the study
Obstetric notes not available
Obstetric
notes Home Other
abstracted Destroyed delivery reason
n (% n (% n (% n (%
Case 489 (88) 24 (4) 26 (5) 16 (3)
GP control 493 (89) 24 (4) 22 (4) 16 (3)
Hospital control 487 (88) 14 (2) 32 (6) 22 (4)
Table V Availability of mother's GP records
to the study
GP records
GP records not
abstracted abstracted
n (%) n (%)
Case 506 (91) 49 (9)
GP control 517 (93) 38 (7)
Hospital control 514 (93) 41 (7)
Table VI Availability of other medical records to the
study
Average
number of
Number of Number of records
records records abstracted
sought abstracted (%) perfamily
Case 1552 1237 (80) 2.2
GP control 1165 889 (76) 1.6
Hospital
control 1349 1062 (79) 1.9
between cases and the two sets of controls within
each region. Failure to abstract the relevant
obstetric records was usually because of unavaila-
bility of the notes. Project staff were very rarely
denied access to the records. A similar uniformly
high level of success was achieved with respect to
obtaining access to GP records (Table V).
Table VI shows the numbers of other types of
medical records from which information was
abstracted. There was less uniformity between
regions and between cases and controls with respect
to this information, but more flexibility was
allowed with respect to which reported diagnoses
would be verified.
Discussion
Successful case-control studies, especially for rare
cancers, are best derived from large populations of
diagnostically confirmed cases, i.e. from good
cancer registries (Frentzel-Beyme & Wagner, 1979).
However, cancer registration is not universally
complete, and histopathological classification of
childhood cancers in particular is difficult. Two of
the strengths of the IRESCC study were the known
high ascertainment of childhood cancer cases in the920 J.M. BIRCH et al.
three regions, and the reliability of the
histopathological diagnoses. Centralised paediatric
oncology services were in operation, and although
case ascertainment was population-based, the
majority of patients were treated in the oncology
centres.
The distribution of diagnoses amongst cases
interviewed is very similar to that seen among the
childhood population of Great Britain as a whole
(Draper et al., 1982). The exceptions were tumours
of the central nervous system, which were compara-
tively under-represented. However, the sample of 81
central nervous system tumours included in the
study comprised examples of each ofthe main types
of brain tumour seen in children (e.g. astrocytomas,
medulloblastomas and ependymomas) in addition
to rarer types of intracranial tumour (e.g. cranio-
pharyngioma and less common types of glioma).
Relatively fewer central nervous system tumours
were treated in the paediatric oncology centres
compared with other tumours, and this probably
accounts for the lower success rate in obtaining
interviews with the parents of these cases.
Nevertheless the study covers a representative
sample of childhood malignant disease.
A very high proportion of parents approached to
take part in this study agreed to participate. The
research associates worked in close liaison with the
medical staff responsible for the care of the
children. Whenever possible, the approach to the
parents was made at a point of optimism in the
child's treatment, usually when the child had com-
pleted his initial therapy and was well. At the time
of interview 96% of the case children were alive, in
contrast to many other studies e.g. The Oxford
Survey of Childhood Cancer, where the majority, if
not all, interviews were carried out a considerable
time after the child's death (Stewart & Kneale,
1970; Sanders & Draper, 1979; Swerdlow et al.,
1982). Our type of approach is recommended for
any future interview studies of the aetiology of
childhood cancer.
Selection of controls is of paramount importance
in any case-control study. Poor selection can lead
to biases and spurious results. The design of our
study involved selection of two controls per case
from two sources. The GP controls represent
random neighbourhood controls, and hospital
controls were selected in part to overcome possible
lack of recall by the GP control parents, since the
hospital control parents had experienced the child's
admission to hospital and the taking of a medical
history.
Reasons for this type of design were: firstly, to
add power to the analyses of results, and secondly,
to avoid some of the biases which may accumulate
in a control group selected from only one source,
even though more than one control may be used
(Cole, 1979). Most previous case-control studies of
childhood cancer have used one control per case.
Two were used in studies of brain tumours (Gold et
al., 1979); parental occupation (Kwa & Fine, 1980;
Hemminki et al., 1981); and tonsillectomy and
Hodgkin's Disease (Vianna et al., 1980). Three
controls were used in a study of environmental
factors in the aetiology of 33 cases of
rhabdomyosarcoma (Grufferman et al., 1982). The
sources of controls in other reported studies of
childhood cancer have included birth registers (e.g.
Stewart & Kneale, 1970; Bithell et al., 1973; Kwa &
Fine, 1980; Grufferman et al., 1982); population
registers (e.g. Abramson et al., 1978; van Steensel-
Moll et al., 1983); or tax lists (Dean et al., 1973).
Siblings were used as controls by Vianna et al.
(1980), and children with cancers of different types
from those being studied, by Gold et al. (1979) and
Swerdlow et al. (1982).
In our study, although each of the several
hospital and GP controls selected for each case was
equally well matched with that case, some biases
may have been operating with respect to which set
of parents agreed to be interviewed, for example,
parents from higher socio-economic groups may
have been more willing to take part in the study.
Similarly, parents who were not native English
speakers may have been reluctant to do so because
of language difficulties, even though interpreters
were offered in these circumstances. However, since
more than 90% of GP controls and more than 85%
of hospital controls were ranked first or second on
the control selection lists, we believe that this
should not lead to biases in the controls.
The policy was to interview both parents, and
this was achieved for half the controls and more
than half of the cases. To have included the father
in a higher proportion of the interviews would have
meant conducting even more during evenings and
weekends. The purpose of having the father present
at the interview in addition to the mother was so
that he could give more detail about his own and
his family's medical histories, and the fact that
proportionately more fathers of cases were present
at the interview than fathers of controls will be
taken into account when analysing certain sections
of the data. Since the parents were given written
information about the types of questions which
would be asked well before the interview, the
absence of the father need not necessarily result in
any serious deficiencies in the data.
The interview concentrated on factors associated
with the child's pre-natal life i.e., drugs and other
substances which may cross the placenta; obstetric
investigative procedures which may affect the
foetus; and genetic factors. More emphasis has beenIRESCC STUDY DESIGN 921
placed on pre-natal factors in the present study
than in previous case-control studies of childhood
cancer (e.g. Sanders & Draper, 1979; Grufferman et
al., 1982), and much more detail has been collected
on, for example, pregnancy drugs, and more
extended pedigree information, than in these
previous studies. Conversely, perhaps less emphasis
has been placed on post-natal events.
Recall of the interviewed subject may be greater
for cases than controls, because the occurrence of
disease in the cases tends to prompt recall
(Feinstein, 1979). The control group should
therefore be stimulated to achieve similar recall,
and efforts should be (but are rarely) made to
validate statements given at interview. In the
IRESCC study, parents of both cases and controls
were given written and sometimes verbal
information about the study, which we hoped
would prompt family discussions and recall. We
also undertook comprehensive validation of
information reported at interview by checking
hospital records, death certificates and cancer
registry records. The extent to which verification of
information gained at interview by reference to
medical records was carried out distinguishes
IRESCC from other studies. This exercise proved
highly successful, and is a reflection of the degree
of interest in the study shown by medical personnel
in all three participating regions. The effects of such
verification of interview information on the
eventual results of case-control studies is discussed
in detail elsewhere (McKinney et al., in
preparation).
Joint discussion sessions with the research
associates from each region were held to ensure
uniformity of interview technique. Nevertheless
there was variation between the regions with respect
to length of interview, but since the data will be
analysed using matched case-control comparisons,
differences between regions in the exact way in
which the interview was carried out are not felt to
be important.
Childhood cancer is rare, and a general prac-
titioner could expect to see only a very few cases in
his working lifetime. Perhaps because of this, the
GPs of the children included in the study were very
helpful. Although priority was given to.the verifi-
cation of certain diagnoses in relatives of the index
child, there were guidelines rather than rigid rules
for this aspect of the study. Also, in the West
Midlands, consultants were asked to complete
questionnaires concerning illnesses among other
family members rather than to lend the notes. This
accounts for the larger number of records sought in
Birmingham, since this was a less time-consuming
procedure than that adopted in Leeds and
Manchester. These points will be taken into con-
sideration when interpreting results of analyses of
these data.
The fact that the study was being carried out in
close collaboration with the consultants responsible
for the treatment of the children may also account
for the extremely co-operative attitude shown by all
those approached to assist with the study.
For the purposes of coding the complete data set
consisting of interview pro formas for the case and
two matched controls, and abstract forms with
respect to obstetric, GP and other medical records,
the method of apportioning the data between the
three regions allowed expertise to be gained in a
limited range of codes. This ensured greater consis-
tency and accuracy than would have been inherent
in a system where each centre coded all its own
data. The coding of information abstracted from
medical records alongside but distinct from the
interview information will allow the two sets of
information to be dealt with separately if this is
desirable for particular analyses. The total data set
consists of approximately one million separately
coded items of information.
In conclusion, IRESCC is an aetiological study
of childhood cancer with a number of unusual
features. The data collection exercise has been
extremely successful, and we anticipate that careful
and detailed analyses of the data will yield
interesting and informative results.
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